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ABSTRACT The new crystal structures of the product-bound ﬁreﬂy luciferase combined with the previously determined
substrate-free structures allow for a detailed analysis of the dynamics basis for the luciferase enzymatic activities. Using the
Gaussian network model and the anisotropic network model, we show here that the superposition of the three slowest anisotropic
networkmodelmodes, consisting of the bending, rotating, and rockingmotions of theC-domain, accounts for large rearrangement
of domains from the substrate-free (open) to product-bound (closed) conformation and thus constitutes a critical component of the
enzyme’s functions. The analysis also offers a unique platform to reexamine themolecular mechanism of the anesthetic inhibition
of the ﬁreﬂy luciferase. Through perturbing the protein backbone network by introducing additional nodes to represent anesthetics,
we found that the presence of two representative anesthetics, halothane and n-decanol, in different regions of luciferase had
distinctively different effects on the protein’s global motion. Only at the interface of theC- andN-domains did the anesthetics cause
themost profound reduction in the overall ﬂexibility of theC-domain and the concomitant increase in the ﬂexibility of the loop, where
the substitution of a conserved lysine residue was found experimentally to lead to.2–3 orders of magnitude reduction in activity.
These anesthetic-induced dynamics changes can alter the normal function of the protein, appearing as an epiphenomenon of
an ‘‘inhibition’’. The implication of the study is that a leading element for general anesthetic action onproteins is to disrupt themodes
of motion essential to protein functions.
INTRODUCTION
Fireﬂy bioluminescence, which converts chemical energy
from luciferin, Mg-ATP, and oxygen into light, is catalyzed
by the enzyme luciferase. This protein belongs to the super-
family of acyl-adenylate-forming and thioester-forming en-
zymes, which have been subjected to intense structural
investigations in recent years (1–6). These enzymes are
believed to adopt two different conformations to catalyze two
half reactions (4): the ﬁrst half is an adenylation reaction to
form an acyl-adenylate from a carboxylate and ATP, and the
second half is either an oxidative decarboxylation in the case
of luciferase or an acyl-group-transfer reaction in other mem-
bers. More generally, the proteins in this superfamily can act
as a multifunctional enzyme—both as oxygenase and ligase
(7,8)—and their activity depends strongly on the concentra-
tions of native substrates as well as the presence of coenzyme
A. The modes of motion to accomplish the large domain
rearrangement, which is essential for function, are yet to be
elucidated.
In a seemingly completely unrelated ﬁeld, luciferase has
also been the focus of the debate on molecular mechanisms
of general anesthesia, a topic that has far-reaching implica-
tions for the physiology of consciousness, arousal and sleep,
and memory formation. It was discovered quite unexpect-
edly some 40 years ago that the bioluminescence activity of
luciferase could be inhibited by general anesthetics (9). This
intriguing ﬁnding (9), along with a more systematic inves-
tigation two decades later with anesthetics over a potency
range of ﬁve orders of magnitude (10), directly challenged
the century-long dominance of the lipid theory of general an-
esthesia and brought the protein theory onto the center stage.
The inhibition of luciferase by anesthetics provided convinc-
ing evidence, showing direct anesthetic interaction with pro-
teins to exert an action. What remains elusive is how protein
functions are modulated by anesthetics. The suggestion—
based on the studies with luciferase—that anesthetics might
‘‘act by competing with endogenous ligands for binding to
speciﬁc receptors’’ (10) and the inference that they might
‘‘act at a relatively small number of sensitive protein targets’’
(11) has led the mainstream anesthesia research onto a path
of searching for speciﬁc and perhaps discrete anesthetic-
sensitive binding sites in the central nervous system. The
past 20 years have witnessed much excitement (12) and dis-
appointment along with a few misinterpretations or overin-
terpretations of experimental results at the molecular, cellular,
and systemic levels. Even with isolated proteins like lucif-
erase, the interpretations of how anesthetic molecules affect
protein functions are controversial (2,13–16).
Although hydrophobic pockets allowing some anesthetic
(or even nonanesthetic) binding undoubtedly exist in pro-
teins, a protein theory based simply on structural ﬁtting to the
yet unidentiﬁed protein targets by anesthetic molecules,
which range from the noble gas xenon to complex steroids,
seems inadequate in explaining and predicting the action of
these drugs. We have proposed an alternative viewpoint of
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anesthetic action based on protein global dynamics (17).
This dynamics-function paradigm can potentially unify the
action of a diverse range of anesthetics on a given protein
based on their ability to modulate the functional mobility of
the protein. We contend that the primary action of general
anesthetics (and possibly other low-afﬁnity drugs) on pro-
teins is to disrupt the modes of motion essential to protein
function. Binding to structurally ﬁtting pockets is often suf-
ﬁcient but not necessary.
Perhaps the most appropriate protein model to test our
hypothesis is again the luciferase, given its susceptibility to
modulations by a diverse range of anesthetics at their re-
spective clinical concentrations. The recent advent of the
high-resolution x-ray structures of the product-bound (aden-
osine 59-monophosphate (AMP) and oxyluciferine) lucifer-
ase from the Japanese Genji-botaru (6), combined with the
previously determined structures of the substrate-free lucif-
erase from the American ﬁreﬂy Photinus pyralis (2,18), pro-
vides the structural basis for understanding the activities
of luciferase. These two species of the enzyme are highly
homologous and have 67% sequence identity and .80%
sequence similarity. Therefore, their structures, representing
two different functional states of luciferase, make a good pair
in this study for us to characterize the intrinsic dynamics of the
enzyme, to delineate the essential link between dynamics and
function of luciferase, and to reveal the susceptibility of
protein motions to anesthetic modulations.
Like other members in the superfamily, luciferase has a
large N-terminal domain (residues 1–436 in the Photinus
pyralis sequence) and a small C-terminal domain (residues
440–550) connected through a short hinge. Fig. 1 depicts the
experimental structures of luciferase in substrate-free and
product-bound states along with the naming of the most
prominent domains and subdomains. The substrate-free struc-
ture represents an ‘‘open’’ conformation with a large solvent-
exposed cleft between the N- and C-domains (Fig. 1 A). In
contrast, the product-bound structure demonstrates a ‘‘closed’’
conformation (Fig. 1 B). The transition from the open to the
closed conformation seems to involve a rigid-body bending of
C-domain toward the N-domain and a ;90 counterclock-
wise rotation of the C-domain relative to the N-domain. Most
of the substrate binding residues determined experimentally,
notably by mutagenesis, are located in the N-terminal domain
forming a cavity in the core of the domain,with an open access
pathway at the cleft. As shown in Fig. 1 B, luciferin binds
at the bottom of the pocket and ATP above it, closer to the
domain interface and the cleft.
The N-terminal domain harbors the L1 loop (residues
198–206), which is a signature sequence in the superfamily
(1,18). Although the N-terminal domain has by itself a
certain unassisted capacity to sustain the biological function
of the enzyme (19), the role of the C-domain is believed to be
absolutely essential for efﬁciency and catalytic yield. The
Lys529 residue in loop L2 (residues 524–533, Fig. 1 A) of the
C-terminal domain has been shown to play a crucial role
in orienting the substrates (20). Most interestingly, all the
invariant residues in the superfamily are located on the cleft-
facing surfaces of both domains or in the hinge-linker seg-
ment. A diverse range of tertiary relationships between the
N- and C-domains has also been found in the x-ray crystal
structures of other luciferase-related proteins (1,3–5), suggest-
ing that the C-domain of these proteins is intrinsically mobile
and its movement relative to the N-domain is essential for
these proteins to carry out their biological functions.
To accurately capture the essential backbone global
dynamics and low-frequency modes of motion relevant to
protein functions, coarse-grained simulation is often sufﬁ-
cient. Recent developments based on the elastic network
normal mode analysis (21,22) conclude that a detailed
description of speciﬁc interresidue interactions is not neces-
sary to correctly characterize the low-frequency motions.
Further reduction of the system complexity by adopting the
one-point-per-residue (usually Ca atom) scheme, such as in
the Gaussian network model (GNM) (23) and anisotropic
network model (ANM) (24), has been shown to successfully
capture a wide range of protein dynamics (25,26). In this
FIGURE 1 Fireﬂy luciferase in (A) an open substrate-
free conformation (PDB: 1BA3) with a large cleft sepa-
rating the C- and N-terminal domains; and (B) a closed
substrate-bound conformation (PDB: 2D1R), where the
C-domain is much closer to the N-domain. The reaction
products, AMP and oxyluciferin, are marked in blue. The
subdomains in the N-domain are highlighted in cyan,
purple, and yellow and labeled accordingly along with
three highly conserved loops. Notice that the primary
difference between the open and closed conformation is the
C-domain arrangement relative to the N-domain.
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study, we used GNM and ANM to analyze luciferase’s
dynamical features that have direct consequences on the
enzymatic activities. On the basis of this analysis, we have
also carried out systematic computational anesthetic docking
using two representative general anesthetics, halothane and
n-decanol, to examine the potential anesthetic interaction
sites in luciferase. Furthermore, we elucidated and quantiﬁed
the speciﬁc anesthetic effects on the global dynamics of lu-
ciferase using GNM and ANM. Taken together, our computa-
tions on luciferase provided new insights into the mechanism
of anesthetic inhibition of luciferase enzymatic activities.
MATERIALS AND METHODS
X-ray structures of luciferase
The x-ray structures of luciferase in the apo form (18), in the substrate-free
conformation but with two bromoform molecules (2), and in the product-
bound conformation (6) were obtained from the Protein Data Bank (PDB
codes: 1LCI, 1BA3, and 2D1R, respectively). Of over 500 residues in
luciferase, only two residues (199 and 200) are unresolved in 1BA3. These
two missing residues were reconstructed using the MODLOOP server (27)
and further energy minimized using the NAMD program (28). All of the
residues in the 2D1R structure are well resolved. In 1LCI, however, many
residues are unresolved in four highly disordered regions. Comparing the
resolved part of 1LCI to 1BA3, the root mean-square deviation (RMSD)
between the two is very small (,1 A˚), consistent with the fact that 1BA3
was obtained by simply soaking the apoluciferase crystal transiently in a
saturated bromoform solution (2). Therefore, the high-resolution structures
of 1BA3 and 2D1R were chosen in this study to represent luciferase
conformations without and with native substrates, respectively.
GNM and ANM
The theoretical description of the GNM and ANM has been detailed
previously (24,29,30). Brieﬂy, both models assume that a protein in its
folded state can be represented by a three-dimensional elastic network of N
nodes placed on Ca atoms (N ¼ the number of residues in the protein). The
pairs of nodes within a cutoff radius of Rc (6.0 and 15 A˚ for GNM and ANM,
respectively), irrespective of whether bonded or nonbonded, are assumed
to be connected by springs with a uniform force constant, g. In GNM (29),
the N 3 N Kirchhoff matrix deﬁnes the topology of interresidue contacts.
The mean-square ﬂuctuations of residue (i ¼ j) or their cross correlations
(i 6¼ j) can be expressed as
ÆDRiDRjæ ¼ 3kBT
g
½G1ij; (1)
where G is the Kirchhoff matrix, kB the Boltzmann constant, T the absolute
temperature, and g the force constant. It is worth mentioning that the g
values do not affect the calculated motional pattern but only the overall
scaling of the amplitude of ﬂuctuation along the protein sequence. In this
study, the g values were determined by reproducing the experimental B
factors of the crystal structures. The beauty of GNM is the possibility to
extract the global motion of a large protein with minimum computational
cost. The dynamic spectrum of a protein can be quickly decomposed with
the GNM analysis into a set of normal modes in which the ﬁrst several slow
modes are usually associated with the functionally relevant motions (25,26,
31,32). However, GNM provides information only on the relative magnitude
of ﬂuctuations. The directionality of the motions can be characterized by
ANM (24), in which the counterpart of the Kirchhoff matrix G in GNM is the
3N 3 3N Hessian matrix, H. ANM decomposes the motion spectrum of a
protein into 3N  6 nonzero eigenvalues and the same number of eigen-
vectors that reveal the respective frequencies and shapes of individual
modes. The inverse of Hessian matrix, H1, is composed of N 3 N super-
elements, and the ith superelement of H1 describes the self-correlations
between the components of DRi. Protein conformational changes induced
by a given mode, k, can be evaluated using the ANM-predicted eigenvector
mANMk as in (33):
½Rð6sÞk ¼ R06skl1=2k mANMk ; (2)
where R0 and R are the vectors of the original and instantaneous Ca
positions, respectively, lk is the eigenvalue, and sk is the scaling parameter
that scales the size of deformation induced by mode k. The formula was
employed to demonstrate the open-to-closed transition of luciferase in this
study.
The software for GNM and ANM calculations was obtained from http://
ribosome.bb.iastate.edu/software.html, and the calculations were run on Dell
Precision 530 workstations equipped with dual Xeon processors. The online
servers developed in the Bahar laboratory (http://ignm.ccbb.pitt.edu/
GNM_Online_Calculation.htm (34,35) and http://ignmtest.ccbb.pitt.edu/
cgi-bin/anm/anm1.cgi) were also used for part of the calculations.
Anesthetic docking
Potential anesthetic interaction sites in luciferase were explored by docking
anesthetic halothane and n-decanol to the substrate-free and product-bound
luciferase using the AutoDock3.0 program (36). The previously optimized
parameter set for halothane (37,38) was used in halothane docking. The
initial structure of n-decanol was obtained from geometry optimization at the
quantum mechanical B3LYP/6-311(G) level of theory using the Gaussian98
suite of programs (39). Default parameters from AutoDock3.0 were adopted
for n-decanol docking. Torsion-angle ﬂexibility was allowed for n-decanol
and halothane molecules. A grid size of 164, 180, and 156 in the X, Y, and Z
dimensions with a spacing resolution of 0.436 A˚ was used in docking. Other
docking conditions, including the Lamarckian genetic algorithm, are the
same as used in our previous studies (40). Favorable docking results were
determined on the basis of low docking energy and high occupancy. At least
100 docking trials were performed for each system with different conﬁgu-
rations of substrate or product binding.
Analysis of anesthetic effects on protein
global dynamics
The nodes representing anesthetic molecules were placed on selected carbon
atoms in GNM calculations. For halothane, a single node was placed on the
CF3 carbon atom. For n-decanol, to achieve the coarse-graining level similar
to that for the protein network, every three carbons were represented by one
node, resulting in four nodes per n-decanol molecule. To verify the
robustness of our results with respect to the coarse graining of the anesthetic
molecules, we also carried out calculations with three or six nodes per
n-decanol molecule and proved that the choice of three, four, or six nodes
per n-decanol did not affect the conclusion. No distinction was made for
interaction potentials between protein and nonprotein nodes. Such an
approximation is reasonable in GNM calculations, where a uniform force
constant was applied to all nodes in the network.
The mean-square ﬂuctuation driven by the global GNM modes of
luciferase in the presence of anesthetics, ÆDR2æ(protein1anesthetics), was
compared with the results from parallel calculations without anesthetics.
Anesthetic-induced dynamics changes were determined using the differences
in the root mean-square ﬂuctuations (RMSF) of luciferase in the presence and
absence of anesthetics, (sqrtÆDR2æ(protein1anesthetics)  sqrtÆDR2æ(protein)).
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RESULTS AND DISCUSSION
Links between dynamics and function
The lowest frequency GNM and ANM modes of luciferase
exhibit the characteristics of concerted motions that coincide
strikingly well with the experimental ﬁndings. The RMSF,
derived from the slowest GNMmode, were color coded onto
the original open and closed structures of luciferase in Fig. 2,
showing that the C-domain is actively engaged in motion
whereas the N-domain is much less involved. The correctness
of the GNM result is clearly evidenced by the substantial
changes in the C-domain orientation in the structures of
substrate-free and product-bound luciferase, whereas the
N-domain conformation remains almost the same with and
without substrate binding.
The highly dynamical nature of the C-domain is reﬂected
not only in the large amplitude of domain ﬂuctuations in the
GNM global mode but also in the directions of domain
motions as revealed by the ANM analyses. In Fig. 3, A–E,
we present four conformational models generated using Eq.
2 by displacing Ca in the open structure along the eigen-
vectors of the three slowest ANM modes. The conforma-
tional transition from the open to the closed conformation
requires a large amplitude movement of the C domain (see
Fig. 3 A) with a downward movement by ;5 A˚ and lateral
rotation of ;90. The Ca RMSD between the open and
closed conformations is .17 A˚ for the C domain when the
two structures are ﬁtted by the N-domain. Because harmonic
approximations near the equilibrium structure are used in the
ANM analysis, the large displacement of this magnitude,
which is beyond the harmonic regime, will undoubtedly
introduce distortions into the secondary structure. Thus, in
determining the scaling factors sk in Eq. 2, we limited sk
values to not exceed 65, with signs producing the ‘‘correct’’
direction of movement toward the closed structure. The sk
values for the ﬁrst three modes were optimized iteratively to
minimize the Ca RMSD of the C-domain between the
transformed structure from Eq. 2 and the experimental closed
structure. The optimized sk values for the ﬁrst three modes
are 9, 37, and 3, respectively, and were used to generate
Fig. 3, B–D, discussed below. The superposition of these
three modes of motion is shown in Fig. 3 E, which reduces
the Ca RMSD of the C-domain from 17 A˚ to 11 A˚. It is
important to emphasize that the ANM eigenvectors cannot
reproduce the complete conformational transition but rather
can only identify the modes of motions that correlate closely
with the directions and the tendency of the functionally im-
portant conformational changes.
The ﬁrst ANMmode of the substrate-free luciferase drives
a downward hinge-bending, cleft-closing movement of the
C-domain (Fig. 3 B). It has been postulated that the motion of
the small C-domain toward the large N-domain in a ‘‘hammer-
and-anvil’’ fashion (41) is induced by ATP binding and
allows all the invariant residues, which are located in the
linker and on the cleft-facing surfaces of the two domains, to
move closer to interact with the substrate. The second slowest
ANM mode drives rotation of the C-domain with respect to
the N-domain, coupled with a slight tilting of the N-domain in
the opposite direction (Fig. 3C). A rockingmotion is revealed
in the third ANM mode (Fig. 3 D). The superposition of the
bending, rotating, and rocking motions results in a confor-
mation, as shown in Fig. 3 E, which constitutes a transition
stage toward the closed conformation of luciferase (Fig. 1 B)
and other homologous proteins crystallized in the ‘‘catalytic’’
states (1). Clearly, the transition between the open and closed
conformations, which respond to the disassociation and as-
sociation of substrates, respectively, is realized through a
hinged, rigid-body movement involving predominately the
C-domain. Such large amplitude movement of the C-domain,
consequently leading to a very different tertiary arrangement,
has been hypothesized to be essential for accommodating the
catalytic reactions by the enzymes in the adenylate-forming
superfamily (5).
FIGURE 2 (A) RMSF driven by the GNM global (ﬁrst) mode in the open
(black) and closed (red) conformations of ﬁreﬂy luciferase. The RMSF
values are mapped onto the (B) open and (C) closed conformations of
luciferase. The low amplitude of N-domain ﬂuctuations (largely in blue) is
in sharp contrast to the high mobility of those of the C-domain (largely in
red and green).
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Besides the aforementioned rigid body movement of the
C-domain that dominates luciferase’s global dynamics, other
motions may also contribute to the enzymatic activity. To
analyze the intrinsic coupling among various residues be-
tween the N- and C-domains or among the subdomains, the
interresidue cross correlation of motions in all GNMmodes is
mapped in Fig. 4, displaying several important dynamic
features. First, the long-range interactions between N- and
C-domains are mainly characterized by a strong and negative
correlation. This ismore so in the open conformation, whereas
added contact points between the N- and C-domains in the
closed conformation moderately reduce the negative correla-
tion between the two domains. Second, the C-domain is
strongly correlatedwithin itself whereas theN-domain,which
contains substrate binding sites, is more diverse in its internal
correlations. Third, loops L1 (residues 198–206) and L2
(residues 524–533) constitute the prominent gaps in the
anticorrelation between C- and N-domains, and their motions
are strongly coupled with each other. This coupling is vividly
displayed in Fig. 2, A and B, in the global mode of the open
conformation, where the tips of the L1 and L2 loops are
‘‘locked’’ into each other with almost identical RMSF
whereas the ‘‘upper’’ part of the L2 loop is quite ﬂexible.
The coupling provides the functionally important dynamical
‘‘contact’’ between the two domains across the cleft. These
features are clearly visible in Fig. 4 in both the substrate-free
and product-bound conformations, though some appear
stronger in one conformation than the other.
To highlight the diverse range of motional correlation
within and among the subdomains, higher GNM modes of
motion are depicted in Fig. 5. Compared to the global mode
(Fig. 2), the collectivity of the higher modes within the
N-domain is signiﬁcantly reduced. In modes 2–5, the ﬂexi-
bility distributions in the N-domain are quite similar for both
conformations. The strongly ﬂuctuating segments of the A, B,
and C subdomains (see Fig. 1 for subdomain naming) are con-
sistently those that are external and solvent exposed.
The cleft between the N- and C-domain is crucial for
luciferase function, and many residues in this region are
either invariant or highly homologous in the superfamily
FIGURE 3 Directionality of conformation transition
from the open to closed structures of luciferase, predicted
by the eigenvectors of the three slowest ANM modes (k ¼
1, 2, 3) using Eq. 2. Note that the N-domain is mostly
immobile, whereas the small domain undergoes large-
amplitude displacement during the open-to-closed transi-
tion. A helix of the C-domain is highlighted in different
colors to help visualize the conformational transitions. (A)
The original open structure (light gray with the red helix);
(B) the original open structure superimposed with a model
(dark gray with the blue helix) resulting from a deforma-
tion of the open conformation along the slowest mode
eigenvector that corresponds to the C-domain downward
bending; (C) the model structure (dark gray with the blue
helix) resulted from the original open structure through a
deformation along the second slowest mode eigenvector
that drives the lateral rotation of C-domain; (D) the model
(dark graywith blue helix) resulted from the open structure
deformed along the third slowest mode eigenvector, the
motion of which can be best described as C-domain rock-
ing laterally between subdomains A and B of N-domain;
and (E) the ﬁnal model structure (blue with the thickened
blue helix) resulted from the original open conformation
through a deformation by the superposition of all three
slowest eigenvectors. The model is superimposed with the
open (light graywith red helix) and the closed (purplewith
the thickened purple helix) conformations. The scaling
factors, sk, are 9, 37, and 3 for B, C, and D, respec-
tively. The same sk parameters were applied for the model
in E. Note that the combined motion yields a conformation
that correlates well with the conformational change leading
to the experimental crystal structure in the closed form.
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(18). Some of the residues at the cleft were implicated in
directing the substrates into the correct position and orien-
tation (20), interacting with the diffusing products, or facil-
itating different stages of catalytic pathway (18). Loop L1,
containing the superfamily signature sequence, has a very
low mobility in the two slowest modes. However, a rel-
atively high ﬂexibility of L1 and L2 is observed in the
substrate-free luciferase in GNM modes 3 and 4. The
enhanced ﬂexibility of both cleft-projecting loops L1 and L2
may promote the reception and accommodation of substrate
molecules in the open conformation. In contrast, these loops
remain rigid in most of the slowest modes in the closed form.
The rigidity of the loops may assist the stabilization of the
productive domain arrangement for acyl-adenylate forma-
tion and ultimately facilitate catalysis and light emission.
Taken together, GNM and ANM calculations captured the
essential dynamics features of luciferase that have direct
implication on the function of the protein. These features
provide us with the basis for elucidating potential anesthetic
effects on luciferase enzymatic activity, as presented below.
Anesthetic interaction sites in luciferase
It has been well documented that the anesthetic modulation
of luciferase activity and the nature of anesthetic interaction
with the enzyme are strongly dependent on the concentration
of Mg-ATP (14,42). At low Mg-ATP concentrations, an-
esthetics have little inhibitory effects on luciferase activity,
suggesting that certain conformational changes upon ATP
binding are required for anesthetics to exert their action. For
a long time, the site at which anesthetics interact with the
enzyme to cause inhibition has remained uncertain. Cocrys-
tallization of luciferase with native substrates or with anes-
thetics has proven to be rather difﬁcult (2). The only crystal
structure of luciferase with two bromoform molecules but
without substrates was obtained by soaking the crystals in
FIGURE 4 Cross correlation of all GNM modes of
ﬁreﬂy luciferase in the (A) open and (B) closed conforma-
tions. Strong positive correlations among residues within
the C-domain indicate a signiﬁcant component of collec-
tive rigid-body movements of the C-domain. Strong
coupling between L1 (residues 198–206) and L2 (524–
533) loops and anticorrelation between the N-domain and
C-domain are clearly visible.
FIGURE 5 MSF driven by GNM
modes 2–5 are color mapped onto the
(A) open and (B) closed conformations
of the ﬁreﬂy luciferase. Notice the loss
of motional collectivity in the N-domain
of both conformations. Modes 3 and 4
exhibit signiﬁcant mobility in loops L1
and L2 of the open form but not in the
closed form.
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the apo form into saturated bromoform (2). Hence, the
relevance of the bromoform site found in the soaked crystal
to the real anesthetic inhibition site has to be taken with
caution, and other vital binding sites may remain unidenti-
ﬁed.
To examine plausible anesthetic interaction sites, we
performed ﬂexible anesthetic docking on both luciferase
conformations. Halothane and n-decanol were chosen for the
study because of their difference in size and the inhibition
potency. The potency of n-decanol is several orders of
magnitude stronger than that of halothane (10). At least two
conclusions can be drawn from the docking study. First, the
distributions of anesthetics in the open and closed forms are
different. As shown in Fig. 6, the cleft region of the closed
luciferase is more energetically favorable for n-decanol. In
comparison, the open form harbors the highest afﬁnity site in
the A subdomain of the N domain. Second, the product-
binding pocket seems to attract anesthetics in both confor-
mations. N-decanol docks to the AMP and oxyluciferin
binding sites in the closed form when the products in the
structure were artiﬁcially removed. There was also a certain
degree of n-decanol afﬁnity for the same cavity in the open
form, although it is not the most favorite docking site.
Another site with lower afﬁnity in the closed form is in the
groove separating subdomains B and C (denoted ‘‘side’’).
Halothane has similar binding proﬁles with signiﬁcant pop-
ulations in all aforementioned sites. Among them, the most
populated site in the open conformation is again located in
subdomain A. Other docking sites, including some scattered
peripheral sites, are with higher docking energy and lower
afﬁnities, consistent with the experimental ﬁnding that hal-
othane has much lower inhibition potency to luciferase than
n-decanol. Detailed anesthetic docking energy and site oc-
cupancy are summarized in Table 1S in the Supplementary
Material.
We hope that our computational predictions of the multiple
low-afﬁnity anesthetic binding sites will prompt further ex-
perimental studies on the enzyme and its interactions with
volatile anesthetics. Experimental measurements of low-
afﬁnity binding with site speciﬁcity prove to be extremely
difﬁcult because most experimental approaches based on the
Scatchard method can only yield the apparent binding con-
stant, which in the case of multiple low-afﬁnity binding sites
is heavily skewed toward the comparatively higher afﬁnity
sites. Cocrystallization with low-afﬁnity drugs is rarely suc-
cessful, and even when well-diffracting crystals are obtained,
FIGURE 6 Results of n-decanol ﬂexible docking in (A)
the open form of luciferase, (B) the closed form with bound
oxyluciferin, (C) the closed form with bound AMP, and
(D) the closed form with bound AMP and oxyluciferin.
Bromoform locations found in 1BA3 are marked by green
spheres in A. Both AMP and oxyluciferin are colored in
dark blue in B–D. Major docked n-decanol clusters are
displayed with different color codes for binding energies:
red, the lowest energy; orange, moderate; and yellow, the
high energy. The n-decanol docking locations are marked
in B–D by their proximity to the functionally important
sites.
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it is often unclear if all possible sites are occupied in the
cocrystals. However, with strategic selective isotopic label-
ing of the backbone and side chains, it is possible in principle
to measure the site-speciﬁc binding constants by NMR
chemical shift perturbation through anesthetic titrations. We
have used this method to measure the halothane binding to a
small soluble protein, ketosteroid isomerase (D. Ma, Y. Xu,
and P. Tang, unpublished data), and conﬁrmed the anesthetic
binding at the sites predicted by our computational studies
(40). Alternatively, with the availability of an increasing
number of synthetic anesthetic agents having photoafﬁnity
probes, it is also possible to explore anesthetic binding by
photoafﬁnity labeling. This method has been successfully
applied (43) using [14C] halothane to some anesthetic targets,
both in soluble and membrane proteins. Indirectly, the ﬁreﬂy
luciferase activity and interaction with anesthetics can be
further studied using point mutations at one of the following
target residues: Asp438, Ser442, Ile444, Glu457, Val471, Ala472,
Gly473, Glu481, and Arg538. These residues are located in the
C-domain within a 4-A˚ radius from the binding site of
n-decanol in the cleft (see Fig. 7, anesthetics in black).
Mutations with amino acids having amphipathic side chains,
such as W and Y, might change the luciferase sensitivity to
anesthetics, thus critically testing our theoretical predictions.
Volatile anesthetics, in general, are low-afﬁnity agents
(12). They can associate with different regions of a protein,
having different effects on protein functions. In the case of
luciferase, above-unity Hill numbers are often found for
various anesthetics, suggesting that these drugs interact with
multiple sites in luciferase. The inhibition concentration of
volatile anesthetics is typically in the hundred-micromolar to
millimolar range (44). Hence, all sites predicted by docking
in Fig. 6 are possible sites for anesthetic interaction, but they
are not necessarily equally important to the inhibition of
luciferase function, as will be discussed below in their
different effects on the functionally important slow modes
of motions. Because the location of the soaked bromoform
molecules in the x-ray structure is adjacent to the luciferin
binding area (2), it has been postulated that anesthetics
compete with substrates for the same site. Other experimen-
tal data, however, suggested that volatile anesthetics and
alcohols inhibited luciferase noncompetitively (9,44,45). It
was also suggested in these studies that anesthetics interacted
with luciferase nonspeciﬁcally and caused destabilization of
luciferase in the absence of Mg-ATP. An opposite effect was
observed later in the presence of Mg-ATP (14). In our
docking studies, if the oxyluciferin was artiﬁcially removed
from the closed structure and its binding pocket was searched
again using AutoDock, 95% occupancy was found at the
same oxyluciferin site. The binding energy for oxyluciferin
is 1.6 kcal/mol lower than n-decanol at the same site. Thus,
even with very potent anesthetics like n-decanol, the afﬁnity
ratio is 14 times in favor of oxyluciferin. Halothane would be
at least three orders of magnitude less competitive than
oxyluciferin for the substrate biding site. In any case, it
FIGURE 7 Differences of the RMSF, sqrtÆDR2æ(protein 1 decanol) 
sqrtÆDR2æ(protein), driven by the global GNM modes between the closed
conformations with and without the docked n-decanol molecules. (A)
Differences of RMSF induced by n-decanol molecules in three slightly
different orientations at the cleft region of luciferase. Line colors in A match
the colors of n-decanol molecules shown in B. Also in B, AMP and
oxyluciferin are marked in pink and cyan, respectively. The regions with
RMSF changes exceeding 60.04 units under the inﬂuence of the anesthetic
nodes are highlighted in yellow and blue, respectively.
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seems unlikely that the inhibition of luciferase by a very
diverse range of anesthetic molecules can result from their
competition with the native substrates or products. It is thus
worth exploring other possible mechanisms of anesthetic
action on luciferase. As discussed in the following section,
the anesthetic modulation of the global dynamics seems highly
relevant to the anesthetic-induced inhibition of luciferase.
Dynamics changes upon anesthetic binding
Although the conventional all-atom molecular dynamics
(MD) simulations of protein systems with docked anesthetics
can provide detailed information about anesthetic-protein
interaction (17,40), the current computational timescale of
MD simulations is often not long enough to directly reveal
anesthetic modulation on functionally relevant dynamics. In
contrast, GNM and ANM analyses can effectively capture
the anesthetic effects on global motion. By perturbing the
protein backbone network with additional nodes to represent
the docked anesthetics, we found that the presence of halo-
thane or n-decanol in different regions of luciferase had
distinctively different impacts on the protein global dynam-
ics. Fig. 7 illustrates the changes in luciferase ﬂuctuations in
the presence and absence of n-decanol in the cleft region of
the closed conformation. An analogous ﬂuctuation proﬁle for
halothane (Fig. 1S in the Supplementary Material) is very
similar in shape but shows smaller amplitude. This ﬁnding
emphasizes the similarity in the mechanism of action exerted
by the different anesthetic molecules. At the same time, the
smaller amplitude of the effect by halothane is consistent
with halothane’s lower anesthetic potency compared to
n-decanol. In the global mode, which directly relates to the
conformational transitions between the open and closed
states as discussed earlier in this article, there is a profound
reduction in ﬂexibility in almost all of the C-domain (as large
as ;20% by comparing the amplitudes in Figs. 2 and 7).
This is consistent with the experimental ﬁnding that
anesthetics stabilize the closed conformation in the presence
of Mg-ATP (14). The stabilization of C-domain in the
product-bound conformation can reduce the enzyme turn-
over, leading to apparent inhibition. Other noticeable changes
when anesthetics bind to the cleft region are the moderate
increase in the ﬂexibility of the residues from T292 to D438
that are in contact with AMP (highlighted in yellow in Fig. 7 B).
Moreover, the dynamics changes are fairly sensitive to the
ﬁne detail of the n-decanol position or orientation in the cleft.
The presence of n-decanol in the cleft region also affects the
all-mode cross correlation distribution, as shown in Fig. 3S
in the online Supplementary Material. Particularly interesting
changes in the correlation patterns can be seen in the L2 loop
and the interdomain linker.
In sharp contrast, the perturbation to the global dynamics
is much smaller when halothane or n-decanol molecules
were placed in other plausible binding sites revealed by the
docking, including the binding sites for oxyluciferin and
AMP (Fig. 8). N-decanol docked at the oxyluciferin site can
only produce local changes in those residues in direct contact
with the anesthetic. It is also worth noting that the slowest
GNMmode is virtually insensitive to the presence or absence
of anesthetics at the lowest energy halothane binding site in
the A subdomain or the bromoform-binding sites (see Fig. 1S
in the Supplementary Material), suggesting that the high
afﬁnity anesthetic binding sites such as those revealed by
soaking open-conformation crystals in saturated anesthetic
solutions are not necessarily the functionally important sites
for anesthetic action. Therefore, the region where anesthetics
can impose the most profound dynamical effect is at the
cleft—the interface between the N- and C-domains of
luciferase. The mode of action is the anesthetic-induced re-
duction of global dynamics of the functional C-domain.
It is important to put the results in Figs. 2 and 3 and those
in Figs. 7 and 8 into perspective with regard to each other. By
the normal mode analysis of the experimental structures in
two important functional conformations, we have established
a link between the slow-mode dynamics and the enzymatic
function. Most importantly, we have demonstrated that the
ﬁrst few slow modes can account for the tendency of the
conformational transition from the open to the closed struc-
tures (Fig. 3). This, combined with the mutagenesis data by
others about the role of cleft-facing residues in enzymatic
activities, suggests that the slow modes of motion of the
C-domain relative to the N-domain make the predominant
contribution to the luciferase enzymatic function. Thus, it
can be inferred that the profound anesthetic modulations among
the slowest GNM and ANM modes, particularly the signif-
icant reduction of the C-domain movement relative to the
N-domain (Fig. 7), suggest that the anesthetic action on this
protein producing the apparent inhibition of enzymatic activ-
ity is through the modulation of the protein global dynamics.
FIGURE 8 Summary of the RMSF differences induced by n-decanol
molecules docked at different regions of luciferase. The calculation of RMSF
difference induced by the individual n-decanol is the same as described in the
Fig. 7 legend. Each curve represents an average of RMSF differences
contributed by a cluster of n-decanol molecules in each speciﬁc region.
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Despite the fact that most of the C-domain exhibits a
reduced slow-mode motion when anesthetics interact with
the cleft region, a signiﬁcant ﬂexibility increase in loop L2
(residues 526–533), which is a signature loop in the C-domain,
is noticeable. A similar ﬂexibility increase is also found from
residues 292 to 302 and from 318 to 333. These residues are
located at the interface of the C- and N-domains and near the
ATP binding site. Lys529 in 1BA3 (homolog Lys531 in
2D1R) in loop L2 is a conserved residue of the acyl-
adenylate-forming enzyme superfamily. Mutation experi-
ments (20,46) suggested that Lys529 is critical for effective
substrate orientation and provides the polar interactions to
facilitate adenylate production. Substitution of Lys529 to
other amino acids was found to result in over 100- to 1000-
fold reduction in enzymatic activities (20). Thus, it is highly
likely that the slackened structural characteristics of loop L2
at the interface of the N- and C-domains and the overall
mobility of the C-domain are the result of evolution for this
superfamily of enzymes to accommodate the need for the
clamping and rotation motion of the C-domain relative to
the N-domain to accomplish their biological functions. The
anesthetic-induced changes in the slow-mode dynamics of
Lys529 and its adjacent residues can affect the interaction of
these residues with ATP. This, combined with the overall
reduction in C-domain global mode motion, may underlie
the apparent inhibition of the enzymatic activities.
The potential impact on higher frequency motions (up to
mode 20) due to the presence of anesthetics in the cleft
region was also examined. We found only scattered and local
changes in ﬂuctuations of loops and segments of subdomains
A and B, as summarized in Fig. 2S in the Supplementary
Material. The eigenvalue distribution is not signiﬁcantly
affected. The largest changes (eigenvalue increase) occur in
modes 3 and 4, consistent with the shapes of these modes
(see Fig. 5) that exhibit high ﬂuctuations of the linker (mode
3) and moderate ﬂuctuations of loops L1 and L2 (mode 4).
These modes are therefore directly affected by the ligand
located in the cleft. It is clear that only in the global mode is
the C domain ﬂuctuation affected signiﬁcantly and non-
locally by the presence of the anesthetic in the cleft region,
leading to a profound impact on luciferase’s function.
Finally, to conﬁrm that the intrinsic dynamics pattern and
anesthetic-induced dynamics changes observed in this study
are not an artiﬁcial consequence of the coarse graining in
GNM and ANM, we have employed a different variant of
elastic network models to include in the calculation all heavy
atoms in anesthetics and protein, including the side chains.
The so-called rotational-translational blocks were used to
simplify the Hessian matrix (32,47). Adopting the method
implemented in elNe´mo (http://www.igs.cnrs-mrs.fr/elnemo/)
(48), we calculated and compared the slowest normal modes
for both n-decanol-free and n-decanol-bound luciferase in
the closed conformation using all heavy atoms. The default
cutoff radius was used. The n-decanol molecule was located
in the cleft area in the locus and orientation corresponding to
that marked in black in Fig. 7. The eigenvalue-weighted av-
erage of the ﬁrst three modes, which corresponds to the GNM
global mode, revealed a similar pattern of change in dynamics,
validating the one-node-per-residue coarse-graining approach
for analyzing slow dynamics.
In summary, our results conﬁrm that as the luciferase
transforms from the substrate-free to the product-bound state,
the protein C-domain engages in a sequence of movements,
including clamping, rotating, and rocking. The slowmodes of
collective C-domain motion dominate the large conforma-
tional change between two functional states. Although anes-
thetics can access many different regions, grooves, or pockets
in luciferase, including luciferin and ATP binding sites, the
anesthetics at the interface ofN- andC-domains have themost
profound impact on the global dynamics of the protein. The
concerted C-domain movement, intimately coupled to the
enzymatic activity, is shown to be highly susceptible to anes-
thetic modulations. Anesthetic-induced dynamics changes,
most notably the reduced motion of the overall C-domain and
altered ﬂexibility in some of the residues adjacent to the ATP
binding site, would most likely change the normal function of
the protein and show up as an epiphenomenon of an in-
hibition. The results presented in this study reinforced our
early viewpoint (17) that the functionally signiﬁcant changes
in dynamics at various sites of a protein are governed pre-
dominantly by the protein’s intrinsic susceptibility to the
environment-controlled dynamical modulations. As long as
the modulators (anesthetics) are present, the global change
in dynamics will occur and will be additive, leading to the
corresponding functional changes. Such a viewpoint offers a
unitary explanation for different anesthetic action on a diverse
range of proteins and can be systematically tested in future
studies on other proteins.
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